Off-Label Drug Repurposing Research for ALS (Amyotrophic Lateral Sclerosis)

Research into off-label drug repurposing research approaches for ALS (Amyotrophic Lateral Sclerosis). AI-powered analysis of mechanisms, evidence, and clinical status.

About Off-Label Drug Repurposing Research

AI-powered analysis of FDA-approved drugs being repurposed for novel indications — metformin, low-dose naltrexone, rapamycin, statins, and more. Leveraging existing safety profiles for new therapeutic hypotheses.

About ALS (Amyotrophic Lateral Sclerosis)

Complete ALS treatment landscape: tofersen, gene therapy, stem cells, and 10+ emerging approaches. AI-analyzed research with safety scores and citations.

Standard of Care: Riluzole, Edaravone (Radicava), Relyvrio — primarily symptom management with modest survival extension.